Furthermore, six parameters of the patients (sex, smoking status, with or without COPD, TNM staging, lymph node metastasis status, and pathological type of tumour) and their association with the CD4+CD25+FOXP3+ Treg percentage were evaluated (Table 2). The gene discussed is FOXP3; the disease is metastatic malignant neoplasm in the lymph nodes.